MIAMI, Nov. 6, 2020 /PRNewswire-PRWeb/ -- DNA® BIOPHARM (DNA®) announced an initiative to educate consumers about maintaining a healthy bladder and incontinence solutions during National Bladder Awareness Month. They recently launched their female urinary incontinence supplement, FEMAXEEN®, designed to maintain a healthy bladder, support urinary tract health, and improve women's overall quality of life.
According to World Health Organization (WHO), the prevalence of urinary incontinence is twice as high in older women as in older men. Two leading factors that impact incontinence are stress and urge. While stress incontinence is the involuntary leaking of urine from exertion, coughing or sneezing, urge incontinence, involves a constellation of issues including frequency, urgency and leakage immediately preceded by urgency. With FEMAXEEN®, women can let go of incontinence and maintain a healthy bladder and urinary flow.
"Raising bladder health awareness and encouraging women to talk about their bladder health is a critical first step in eliminating the stigma associated with incontinence," said Oscar del Cid, President and CEO of DNA®. "We want women to have the ability to be open to talking about their incontinence and understand that FEMAXEEN® is a safe supplement regimen that will help to maintain a healthy bladder and most importantly, enjoy life without having to worry about leakage."
FEMAXEEN® has active ingredients that helps women improve their quality of life by alleviating stress, urge and mixed urinary incontinence. Pumpkin seed extract is one of the key ingredients that will help support lower urinary tract health and keep control of urine flow.
In celebration of National Bladder Awareness Month, FEMAXEEN® is offering 15% off purchases with promo code BLADDER15.
To purchase FEMAXEEN® visit https://femaxeen.com.
About FEMAXEEN®
FEMAXEEN® is distributed by DNA BIOPHARM ® as s dietary supplement that supports lower urinary tract health. A complete solution for women's incontinence, FEMAXEEN® has been tested and evaluated through a randomized, double-blind, placebo-controlled study with findings citing a 45.3% reduction in incontinence within two months. Now available in the U.S., FEMAXEEN® can be purchased without a prescription.
About DNA BIOPHARM ®
Founded in 1992, DNA® has done business in over 25 countries, covering six continents, and currently operating in America (Miami), Mexico (Mexico City) Europe (Budapest, Hungary), and Africa (Cape Town, South Africa). In 2013, DNA Mexico became one of the largest distributors of The Day After Pill after introducing the pill in 2003 and selling about 30,000,000 units within a 10-year period. Today, DNA® continues to manufacture and distribute a comprehensive line of products that target a wide range of health issues ranging from immune deficiency, psoriasis, acne, adrenal stability, incontinence, and more. DNA® is poised to continue great leaps forward with their tradition of growth, quality, and service worldwide.
SOURCE DNA BIOPHARM
Share this article